Webbplatsen kommer inte fungerar helt korrekt om er webbläsares JavaScript funktion är inaktiverad.
Treating low back pain

Stayble Therapeutics

Stayble Therapeutics develops an injectable treatment against chronic low back pain triggered by disc degeneration. The treatment is presumed to last the patient’s entire life and require minimal rehabilitation.

Stayble Therapeutics


Andreas Gerward

First investment year:


Business sector:

Life Science, Drug development

Investment manager: Patrik Sjöstrand Visit website